Literature DB >> 12481719

Mechanisms of drug resistance in AML.

Michael Andreeff1, Marina Konopleva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12481719     DOI： 10.1007/978-1-4615-1173-1_12

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  4 in total

1.  Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia.

Authors:  Kui Song; Min Li; Xiaojun Xu; L I Xuan; Guinian Huang; Qifa Liu
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

2.  Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.

Authors:  Harald Herrmann; Irina Sadovnik; Gregor Eisenwort; Thomas Rülicke; Katharina Blatt; Susanne Herndlhofer; Michael Willmann; Gabriele Stefanzl; Sigrid Baumgartner; Georg Greiner; Axel Schulenburg; Niklas Mueller; Werner Rabitsch; Martin Bilban; Gregor Hoermann; Berthold Streubel; Daniel A Vallera; Wolfgang R Sperr; Peter Valent
Journal:  Blood Adv       Date:  2020-10-27

Review 3.  Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

Authors:  Axel Schulenburg; Katharina Blatt; Sabine Cerny-Reiterer; Irina Sadovnik; Harald Herrmann; Brigitte Marian; Thomas W Grunt; Christoph C Zielinski; Peter Valent
Journal:  J Hematol Oncol       Date:  2015-02-25       Impact factor: 17.388

Review 4.  Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.

Authors:  Peter Valent; Karin Bauer; Irina Sadovnik; Dubravka Smiljkovic; Daniel Ivanov; Harald Herrmann; Yüksel Filik; Gregor Eisenwort; Wolfgang R Sperr; Werner Rabitsch
Journal:  Stem Cells Transl Med       Date:  2020-07-13       Impact factor: 6.940
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.